Oklo Inc

Oklo Inc (NYSE: OKLO) is an advanced nuclear technology company focused on developing fast fission power plants that deliver clean, reliable, and scalable energy. Its Aurora reactors provide 24/7 power through long-term agreements, while the company also advances fuel recycling technologies and expands into radioisotope production for medical and industrial applications.

Financial Position For the fiscal year ended December 31, 2025 (FY25)

• Robust Liquidity Position Backed by Capital Raise: Oklo Inc. significantly strengthened its financial position during FY2025, supported by successful equity financings that materially enhanced liquidity. The company reported cash and marketable securities of approximately USD 1.4 billion as of December 31, 2025, a substantial increase driven primarily by USD 1.26 billion raised through follow-on and at-the-market offerings. This strong cash base provides adequate runway to fund ongoing project deployment and long-term strategic initiatives.

Profitability and Expense Trends

• Elevated Losses Reflecting Investment Phase Expansion: The company reported a loss before income taxes of USD 110.2 million and a loss from operations of USD 139.3 million in FY2025, reflecting continued investment in scaling operations. The rise in operating expenses was largely driven by higher payroll costs, professional fees, and stock-based compensation expenses of approximately USD 41.8 million. These trends indicate that Oklo remains in a high-investment, pre-revenue scaling phase focused on building core infrastructure.

Cash Flow and Capital Allocation

• Sustained Cash Utilization to Support Strategic Buildout: Cash used in operating activities stood at USD 82.2 million during FY2025, primarily reflecting net losses adjusted for non-cash expenses and working capital changes. Additionally, investing activities saw significant outflows toward property, plant, equipment, and marketable securities, highlighting disciplined capital deployment into long-term assets. Despite elevated cash burn, strong financing inflows ensured a net increase in cash reserves, supporting ongoing execution.

Operational Execution – Power Segment

• Progression from Development to Deployment Stage: Operationally, Oklo transitioned from product development to active project deployment during 2025, marking a critical inflection point. The company broke ground on its Aurora Powerhouse at Idaho National Laboratory (INL) and advanced construction activities, including site preparation and procurement of major equipment such as power conversion systems. Regulatory progress was also notable, with approvals under DOE pathways enabling continued development and positioning the project for eventual commercialization.

Commercial Partnerships and Revenue Visibility

• Strategic Agreements Strengthening Future Revenue Pipeline: Oklo executed key commercial agreements, most notably a prepayment arrangement with Meta to support the development of a 1.2 GW Aurora power campus in Ohio. This agreement introduces a structured prepayment-for-power model, enhancing project certainty and enabling early-stage funding for fuel procurement and infrastructure development. Such partnerships highlight growing demand for reliable baseload power, particularly from data center operators.

Fuel and Supply Chain Development

• Integrated Fuel Strategy Enhancing Deployment Scalability: The company made significant progress in building its fuel value chain, a critical enabler for nuclear deployment. Oklo advanced construction of its Aurora Fuel Fabrication Facility (A3F), secured DOE approvals, and initiated development of a flagship fuel recycling facility in Tennessee. Additionally, strategic collaborations, including a potential joint venture with Centrus, aim to strengthen upstream fuel supply capabilities. This integrated approach reduces dependency risks and enhances long-term scalability.

Isotope Business and Diversification

• Expansion into High-Value Isotope Markets: Oklo continued diversifying its business model through its isotope segment, supported by the acquisition of Atomic Alchemy and progress at the Groves test reactor facility in Texas. Construction milestones were achieved rapidly, alongside regulatory approvals and fuel procurement. The Idaho Radiochemistry Laboratory also secured licensing and is expected to generate initial revenue, establishing a new income stream and strengthening the company’s multi-segment platform.

Key Risks:

• Execution & Project Delivery Risk: Delays in construction, procurement, or commissioning of key assets (Aurora, fuel facilities, Groves reactor) could impact timelines and cost efficiency.
• Regulatory & Licensing Uncertainty: Dependence on DOE and NRC approvals exposes the company to potential delays or changes in nuclear regulatory frameworks.
• High Cash Burn & Funding Dependence: Continued operating losses and capital-intensive expansion may require additional financing, creating dilution or funding risks.
• Fuel Supply Chain Constraints: Limited availability and sourcing challenges of HALEU and recycled fuels could restrict deployment scalability and increase costs.

Technical Observation (on the daily chart):

• The stock exhibits a long consolidation phase following a prior sharp rally, with price action largely moving sideways over recent months, indicating lack of strong directional conviction.
• The price is currently trading above both the 20-day MA (USD 57.13) and 50-day MA (USD 59.74), suggesting a short-term bullish bias. The recent upward crossover and price holding above these averages indicate improving momentum.
• RSI is hovering around 63, reflecting moderate bullish momentum but approaching overbought territory. This suggests room for further upside, though near-term consolidation or minor pullback cannot be ruled out.
• The stock appears to be forming a base after a prolonged downtrend from its peak (~USD 190+), with higher lows gradually emerging—an early sign of potential trend reversal if sustained.
• Volume has seen a recent uptick, supporting the latest price move, which adds credibility to the ongoing recovery attempt. However, sustained high volumes are needed for a confirmed breakout.

Overall, Oklo’s FY2025 performance reflects a capital-intensive growth phase, characterized by strong balance sheet expansion, rising operating losses due to strategic investments, and meaningful operational progress across power, fuel, and isotope segments. The company’s transition toward deployment, supported by regulatory milestones and commercial partnerships, positions it for long-term value creation within the advanced nuclear energy ecosystem.

As per the above-mentioned price action, recent key business and financial updates, momentum in the stock over the last month, and technical indicators analysis, a ‘Speculative Buy’ rating has been given to Oklo Inc (NYSE: OKLO) at the closing market price of USD 71.00, as of April 24,2026.

Individuals can evaluate the stock based on the support and resistance levels provided in the report in case of keen interest taking into consideration the risk-reward scenario.

Markets are trading in a highly volatile zone currently due to certain macro-economic issues and prevailing geopolitical tensions. Therefore, it is prudent to follow a cautious approach while investing.

Related Risk: This report may be looked at from a high-risk perspective and a recommendation is provided for a short duration. This report is solely based on technical parameters, and the fundamental performance of the stocks has not been considered in the decision-making process. Other factors which could impact the stock prices include market risks, regulatory risks, interest rates risks, currency risks, social and political instability risks etc.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance level is April 24,2026. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Target Price refers to a price level that the stock is expected to reach as per the relative valuation method and or technical analysis taking into consideration both short-term and long-term scenarios.

Note 5: ‘Kalkine reports are prepared based on the stock prices captured either from the New York Stock Exchange (NYSE), NASDAQ Capital Markets (NASDAQ), and or REFINITIV. Typically, all sources (NYSE, NASDAQ, or REFINITIV) may reflect stock prices with a delay which could be a lag of 15-20 minutes. There can be no assurance that future results or events will be consistent with the information provided in the report. The information is subject to change without any prior notice.